Zhao Na-Na, Cao Hui, Zhang Shi-Si, Cao Guo-Qiang
Department of Respiratory Medicine, Institute of Surgery Research, The Third Affiliated Hospital, The Third Military Medical University, Chongqing 400042, P.R. China.
Department of Radiology, Institute of Surgery Research, The Third Affiliated Hospital, The Third Military Medical University, Chongqing 400042, P.R. China.
Exp Ther Med. 2017 May;13(5):2094-2096. doi: 10.3892/etm.2017.4196. Epub 2017 Mar 8.
The present report describes a case of diffuse panbronchiolitis (DPB) in a child from Western China and the favorable outcome associated with early diagnosis. DPB is an uncommon presentation in pediatric patients. A 13-year-old Chinese boy was admitted to the respiratory outpatient department due to recurrent cough and progressive exertional dyspnea that had persisted for 1 year. An initial diagnosis of bronchial asthma was made, and the patient was prescribed inhaled fluticasone combined with salmeterol (50/250 µg, twice daily), and montelukast (4 mg daily). However, 2 months later no clinical improvement was observed. The disease was re-diagnosed as DPB following the identification of features such as centrilobular small nodular opacities, a 'tree-in-bud appearance' and thickening of the bronchial walls meeting the diagnostic criteria for DPB. Complete resolution of the disease and sustained alleviation of the patient's respiratory symptoms were achieved following the early institution of erythromycin therapy, and the exacerbation of chronic bronchitis was reduced. In conclusion, it is essential to consider that successful treatment for DPB lies in early diagnosis and early treatment. DPB may be treated well by use of erythromycin.
本报告描述了一名来自中国西部儿童的弥漫性泛细支气管炎(DPB)病例以及早期诊断带来的良好预后。DPB在儿科患者中并不常见。一名13岁中国男孩因反复咳嗽和进行性劳力性呼吸困难持续1年而入住呼吸门诊。最初诊断为支气管哮喘,患者被处方吸入氟替卡松联合沙美特罗(50/250μg,每日两次)以及孟鲁司特(每日4mg)。然而,2个月后未观察到临床改善。在发现具有符合DPB诊断标准的小叶中心性小结节状混浊、“树芽征”和支气管壁增厚等特征后,该疾病被重新诊断为DPB。早期应用红霉素治疗后,疾病完全缓解,患者呼吸道症状持续减轻,慢性支气管炎的发作也减少了。总之,必须认识到DPB的成功治疗在于早期诊断和早期治疗。使用红霉素可能会很好地治疗DPB。